Evidence map›Paper›PMID 40369157›Full record

ArticleTransgenic research2025

Phenotypic characteristics of interspecific hybrids between wild and cultivated soybean with and without insect-protected biotechnology traits.

Duška Stojšin, Bill Duncan, Chen Meng

Abstract read
In one paragraph

Article in Transgenic research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Duška StojšinBayer Crop Science, St. Louis, MO, USA. duska.stojsin@bayer.com.
Bill DuncanBayer Crop Science, St. Louis, MO, USA.
Chen MengBayer Crop Science, St. Louis, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wild soybean (Glycine soja Sieb. and Zucc.) and cultivated soybean (Glycine max (L) Merr.) can cross-pollinate, albeit at a very low frequency, potentially resulting in an interspecific hybrid with a biotechnology trait inherited from the cultivated soybean parent. As part of environmental risk assessment, it is informative to understand the competitiveness potential of these hybrids in natural habitats. The objective of this research was to evaluate the phenotypic characteristics of the interspecific hybrids and compare them with cultivated and wild soybean. Secondly, the comparisons were conducted between the interspecific hybrids with and without an insect-protected (IP) biotechnology trait. Two wild soybean populations were crossed with cultivated soybean containing either MON 87701 or MON 87751, the IP traits developed to control specific lepidopteran pests. Hybrid plants with and without the IP trait and parental entries were evaluated in growth chamber trials for the plant, pollen and seed characteristics. Compared to the parents, the hybrids had intermediate values for most of the measured characteristics. Compared to the wild soybean parent, hybrids had less twining, shorter plants, fewer seeds and pods, thicker stems, bigger seeds and pollen grains, as well as reduced seed dormancy-all due to domestication genes inherited from cultivated soybean. However, when compared to parents, hybrids had significantly reduced pollen viability (51.8-73.3% vs. > 95%) and number of seeds per pod (1.6-1.7 vs. 2.3) indicating partial reproductive sterility due to chromosome interchange between nonhomologous chromosomes. Seed coat color of the F

Indexed as

Glycine maxPlants, Genetically ModifiedAnimalsBiotechnologyHybridization, GeneticInsectaPhenotypePollenPollinationSeedsInsect-protected biotechnology traitsInterspecific hybridsPhenotypic characterization

Identifiers

PMID40369157
PMCPMC12078375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.